Home > Compound List > Compound details
13024-90-3 molecular structure
click picture or here to close

2-(4-chlorophenyl)-5-methyl-2,3-dihydro-1H-pyrazol-3-one

ChemBase ID: 108517
Molecular Formular: C10H9ClN2O
Molecular Mass: 208.64426
Monoisotopic Mass: 208.0403406
SMILES and InChIs

SMILES:
Cc1cc(=O)n([nH]1)c1ccc(Cl)cc1
Canonical SMILES:
Clc1ccc(cc1)n1[nH]c(cc1=O)C
InChI:
InChI=1S/C10H9ClN2O/c1-7-6-10(14)13(12-7)9-4-2-8(11)3-5-9/h2-6,12H,1H3
InChIKey:
BNMJZURGOFYNQV-UHFFFAOYSA-N

Cite this record

CBID:108517 http://www.chembase.cn/molecule-108517.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
2-(4-chlorophenyl)-5-methyl-2,3-dihydro-1H-pyrazol-3-one
IUPAC Traditional name
2-(4-chlorophenyl)-5-methyl-1H-pyrazol-3-one
Synonyms
1-(p-CHLOROPHENYL)-3-METHYL-5-PYRAZOLONE
CAS Number
13024-90-3
PubChem SID
162094338
PubChem CID
3442874

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID Price
MP Biomedicals
05207673 external link Add to cart Please log in.
Data Source Data ID
PubChem 3442874 external link

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem
Acid pKa 8.266358  H Acceptors
H Donor LogD (pH = 5.5) 1.8802236 
LogD (pH = 7.4) 1.8290405  Log P 1.8809224 
Molar Refractivity 66.9398 cm3 Polarizability 20.93281 Å3
Polar Surface Area 32.34 Å2 Rotatable Bonds
Lipinski's Rule of Five true 

PROPERTIES

PROPERTIES

Safety Information Product Information Bioassay(PubChem)
MSDS Link
Download expand Show data source
Certificate of Analysis
Download expand Show data source

DETAILS

DETAILS

MP Biomedicals MP Biomedicals
MP Biomedicals - 05207673 external link
MP Biomedicals Rare Chemical collection

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    No data available
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle